| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Chemical Industry Institute of Toxicology, Department of Experimental Pathology and Toxicology, Research Triangle Park, North Carolina 27709
In order to characterize the promoting activity of the peroxisome proliferator [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (WY-14,463), male F344 rats which received a single 150-mg/kg dose of diethylnitrosamine (DEN) were fed 0.1% WY-14,643 or 0.05% phenobarbital in the diet for 11, 22, or 54 wk. WY-14,463 promoted the development of ATPase-deficient foci but not GGTase-positive or G6Pase-deficient foci, in contrast to phenobarbital which promoted development of foci detected by all three markers. The mode of promotion of ATPase-deficient foci by WY-14,643 was distinctly different from that of phenobarbital. WY-14,643 primarily increased mean volume of foci at 11 and 22 wk, while phenobarbital primarily increased the numerical density of foci at these time points. At 54 wk, the yield of hepatic neoplasms per liver was higher in rats fed WY-14,643 than in rats fed phenobarbital. To evaluate the possibility that the promotional activity of WY-14,643 was more effective at a later stage in hepatocarcinogenesis, rats receiving a dose of DEN and then phenobarbital in the diet for 11 wk were changed to a diet containing WY-14,643 for an additional 11 or 43 wk. However, WY-14,643 feeding from wk 11 to 22 caused a reduction in volume density of ATPase-deficient foci relative to the volume density of foci at 11 wk. In addition, feeding WY-14,643 from wk 11 to 54 caused similar yields of hepatic neoplasms whether or not phenobarbital was fed for the initial 11 wk. WY-14,643 induced hepatic peroxisome proliferation as indicated by palmitoyl CoA oxidase activity regardless of prior treatment with DEN and/or phenobarbital. The yield of neoplasms in rats not receiving DEN was greater in rats fed WY-14,643 for wk 11 to 54 than in rats fed WY-14,643 for wk 1 to 54. In summary, the peroxisome proliferator WY-14,643 was a more efficient promoter of hepatocarcinogenesis in DEN-initiated rats than phenobarbital. The promotional activity of WY-14,643, when evaluated by stereological analysis and by changing promoters, is distinct from that of phenobarbital, perhaps suggesting different cellular and/or molecular mechanisms of promotion. Understanding the role of promotion by WY-14,643 and other peroxisome proliferators may be important in understanding the mechanism of their hepatocarcinogenicity.
1 Supported in part by CA 07945, USPHS, through the Department of Pathology, University of North Carolina at Chapel Hill. Present address: College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606.
2 To whom requests for reprints should be addressed.
Received 5/10/88. Revised 2/15/89. Accepted 3/17/89.
This article has been cited by other articles:
|
|
 |
|
  C. Michel, C. Desdouets, M. Slaoui, K. R. Isaacs, R. A. Roberts, and E. Boitier Diethylnitrosamine Initiation Does Not Alter Clofibric Acid Induced Hepatocarcinogenesis in the Rat Toxicol. Sci., September 1, 2007; 99(1): 58 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Trapp, M. Schwarz, and B. Epe The Peroxisome Proliferator WY-14,643 Promotes Hepatocarcinogenesis Caused by Endogenously Generated Oxidative DNA Base Modifications in Repair-Deficient Csbm/m/Ogg1-/- Mice Cancer Res., June 1, 2007; 67(11): 5156 - 5161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Xiao, S. P. Anderson, C. Swanson, R. Bahnemann, K. A. Voss, A. J. Stauber, and J. C. Corton Activation of Peroxisome Proliferator-Activated Receptor Alpha Enhances Apoptosis in the Mouse Liver Toxicol. Sci., August 1, 2006; 92(2): 368 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Glauert, A. Eyigor, J. C. Tharappel, S. Cooper, E. Y. Lee, and B. T. Spear Inhibition of Hepatocarcinogenesis by the Deletion of the p50 Subunit of NF-{kappa}B in Mice Administered the Peroxisome Proliferator Wy-14,643 Toxicol. Sci., April 1, 2006; 90(2): 331 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Stauber, H. Brown-Borg, J. Liu, M. P. Waalkes, A. Laughter, R. A. Staben, J. C. Coley, C. Swanson, K. A. Voss, J. J. Kopchick, et al. Constitutive Expression of Peroxisome Proliferator-Activated Receptor {alpha}-Regulated Genes in Dwarf Mice Mol. Pharmacol., March 1, 2005; 67(3): 681 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Howroyd, C. Swanson, C. Dunn, R. C. Cattley, and J. C. Corton Decreased Longevity and Enhancement of Age-Dependent Lesions in Mice Lacking the Nuclear Receptor Peroxisome Proliferator-Activated Receptor {alpha} (PPAR{alpha}) Toxicol Pathol, August 1, 2004; 32(5): 591 - 599. [Abstract] [PDF]
|
|
|
|
 |
|
 O. Moennikes, S. Stahl, P. Bannasch, A. Buchmann, and M. Schwarz WY-14,643-mediated promotion of hepatocarcinogenesis in connexin32-wild-type and connexin32-null mice Carcinogenesis, September 1, 2003; 24(9): 1561 - 1565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Ledda-Columbano, A. Perra, D. Concas, C. Cossu, F. Molotzu, C. Sartori, H. Shinozuka, and A. Columbano Different Effects of the Liver Mitogens Triiodo-Thyronine and Ciprofibrate on the Development of Rat Hepatocellular Carcinoma Toxicol Pathol, January 1, 2003; 31(1): 113 - 120. [Abstract] [PDF]
|
|
|
|
|
|
J. S. Isenberg, L. M. Kamendulis, D. C. Ackley, J. H. Smith, G. Pugh Jr., A. W. Lington, R. H. McKee, and J. E. Klaunig Reversibility and Persistence of Di-2-ethylhexyl Phthalate (DEHP)- and Phenobarbital-Induced Hepatocellular Changes in Rodents Toxicol. Sci., December 1, 2001; 64(2): 192 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Ledda-Columbano, A. Perra, R. Loi, H. Shinozuka, and A. Columbano Cell Proliferation Induced by Triiodothyronine in Rat Liver Is Associated with Nodule Regression and Reduction of Hepatocellular Carcinomas Cancer Res., February 1, 2000; 60(3): 603 - 609. [Abstract] [Full Text]
|
|
|
|
|
|
G.M. Ledda-Columbano, A. Perra, R. Piga, M. Pibiri, R. Loi, H. Shinozuka, and A. Columbano Cell proliferation induced by 3,3',5-triiodo-L-thyronine is associated with a reduction in the number of preneoplastic hepatic lesions Carcinogenesis, December 1, 1999; 20(12): 2299 - 2304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Miyamoto, A. Kaneko, T. Kakizawa, H. Yajima, K. Kamijo, R. Sekine, K. Hiramatsu, Y. Nishii, T. Hashimoto, and K. Hashizume Inhibition of Peroxisome Proliferator Signaling Pathways by Thyroid Hormone Receptor. COMPETITIVE BINDING TO THE RESPONSE ELEMENT J. Biol. Chem., March 21, 1997; 272(12): 7752 - 7758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Ledwith, C. J. Pauley, L. K. Wagner, C. L. Rokos, D. W. Alberts, and S. Manam Induction of Cyclooxygenase-2 Expression by Peroxisome Proliferators and Non-tetradecanoylphorbol 12,13-Myristate-type Tumor Promoters in Immortalized Mouse Liver Cells J. Biol. Chem., February 7, 1997; 272(6): 3707 - 3714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Ma, D. A. Stoffregen, G. D. Wheelock, J. A. Rininger, and J. G. Babish Discordant Hepatic Expression of the Cell Division Control Enzyme p34cdc2 Kinase, Proliferating Cell Nuclear Antigen, p53 Tumor Suppressor Protein, and p21Waf1 Cyclin-Dependent Kinase Inhibitory Protein after WY14,643 ([4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthio]Acetic Acid) Dosing to Rats Mol. Pharmacol., January 1, 1997; 51(1): 69 - 78. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
